Search Results - "Mehta, Roopa"

Ectopic Cushing Syndrome Due to a Large Mediastinal Neuroendocrine Tumor.

Authors: Ramírez-García, Jorge Alberto Garza-García, Gabriela Mehta, Roopa et al.

Source: JCEM Case Reports. Mar2026, Vol. 4 Issue 3, p1-6. 6p.

Disruption to diabetes and hypertension care during the COVID-19 pandemic in Latin America and the Caribbean and mitigation approaches: a scoping review.

Authors: Ogungbe, Oluwabunmi Jabakhanji, Samira Barbara Mehta, Roopa et al.

Source: BMC Health Services Research. 5/8/2025, Vol. 25 Issue 1, p1-18. 18p.

Delphi Consensus on the Use of Fenofibrate as Systemic Therapy for the Prevention of Diabetic Retinopathy Progression.

Authors: O'Brien, Richard C. Abdallah, Khalifa Dong, Xuehong et al.

Source: Journal of Diabetes. Feb2026, Vol. 18 Issue 2, p1-11. 11p.

The status of care for youth with type 1 diabetes within and coming from humanitarian crises settings: a narrative review.

Authors: James, Steven Jabakhanji, Samira B. Mehta, Roopa et al.

Source: Conflict & Health. 1/14/2025, Vol. 19 Issue 1, p1-13. 13p.

Impaired Cardiorespiratory Fitness in Type 1 Diabetes Is Associated With Metabolic Inflexibility and Specific Factors According to Sex.

Authors: Muñoz‐Hernandez, Liliana Paez‐Mayorga, Jesus Flores‐Brito, Jesus et al.

Source: Journal of Diabetes. Dec2025, Vol. 17 Issue 12, p1-11. 11p.

Lipoprotein (a) levels and clinical decision-making: data from a Mexican cohort at a tertiary medical institution.

Authors: Cruz-Bautista, Ivette Flores-Jurado, Yuscely Roa-Álvarez, Guillermo et al.

Source: Lipids in Health & Disease. 5/26/2025, Vol. 24 Issue 1, p1-12. 12p.

Remission of Statin-associated Autoimmune Necrotizing Myopathy With Sequential Immunotherapy: A Well-studied Patient.

Authors: Gómez-Pérez, Francisco J Chiquete-Anaya, Erwin Moncayo-Sánchez, Andrea G et al.

Source: JCEM Case Reports. May2025, Vol. 3 Issue 5, p1-5. 5p.

Barriers to the Use of Insulin Therapy and Potential Solutions: A Narrative Review of Perspectives from the Asia–Pacific Region.

Authors: Chen, Roger Aamir, Azizul Hasan Feroz Amin, Mohammod et al.

Source: Diabetes Therapy. Jun2024, Vol. 15 Issue 6, p1261-1277. 17p.

Latin American Expert Consensus for Comprehensive Management of Type 2 Diabetes from a Metabolic–Cardio–Renal Perspective for the Primary Care Physician.

Authors: Mehta, Roopa Pichel, Daniel Chen-Ku, Chih Hao et al.

Source: Diabetes Therapy. 2021, Vol. 12 Issue 1, p1-20. 20p.

Consensus statement on standardizing CGM evaluation metrics in Latin America: an expert approach.

Authors: Scharf, Mauro Feriz, Karen Yepes, Carlos et al.

Source: Diabetology & Metabolic Syndrome. 7/21/2025, Vol. 17 Issue 1, p1-16. 16p.

Young Adults with Type 1 Diabetes' Clinical Outcomes and Satisfaction Related to the Use of Videoconferencing for Type 1 Diabetes Healthcare: A Narrative Review.

Authors: James, Steven Saiyed, Mahira James, Olive et al.

Source: Diabetes Therapy. Mar2025, Vol. 16 Issue 3, p329-348. 20p.

LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred.

Authors: Mehta, Roopa Elías-López, Daniel Martagón, Alexandro J. et al.

Source: Lipids in Health & Disease. 7/13/2021, Vol. 20 Issue 1, p1-18. 18p.

Trends in the prevalence of metabolic syndrome and its components in Mexican adults, 2006-2018.

Alternate Title: Tendencia en la prevalencia de síndrome metabólico y sus componentes en adultos mexicanos, 2006-2018.

Authors: Rojas-Martínez, Rosalba Aguilar-Salinas, Carlos A. Romero-Martínez, Martín et al.

Source: Salud Pública de México. Nov/Dec2021, Vol. 63 Issue 6, p713-724. 12p.

Subjects: TYPE 2 diabetes, ADULTS, METABOLIC syndrome, CARDIOVASCULAR diseases

Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.

Authors: Elías-López, Daniel Vargas-Vázquez, Arsenio Mehta, Roopa et al.

Source: BMC Endocrine Disorders. 4/28/2021, Vol. 21 Issue 1, p1-12. 12p.

Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST Trials.

Authors: Fulcher, Greg Mehta, Roopa Fita, Edmond G. et al.

Source: Diabetes Therapy. Feb2019, Vol. 10 Issue 1, p107-118. 12p.

Cost-Effectiveness of Insulin Degludec vs. Insulin Glargine U100 in Type 1 and Type 2 Diabetes Mellitus in a UK Setting.

Authors: Evans, Marc Mehta, Roopa Gundgaard, Jens et al.

Source: Diabetes Therapy. Oct2018, Vol. 9 Issue 5, p1919-1930. 12p.

Familial hypertriglyceridemia: an entity with distinguishable features from other causes of hypertriglyceridemia.

Authors: Cruz-Bautista, Ivette Huerta-Chagoya, Alicia Moreno-Macías, Hortensia et al.

Source: Lipids in Health & Disease. 2/15/2021, Vol. 20 Issue 1, p1-13. 13p.

Estimated incidence of cardiovascular complications related to type 2 diabetes in Mexico using the UKPDS outcome model and a population-based survey.

Authors: Reynoso-Noverón, Nancy Mehta, Roopa Almeda-Valdes, Paloma et al.

Source: Cardiovascular Diabetology. 2011, Vol. 10 Issue 1, p1-9. 9p. 6 Charts.

Comparative assessment of LDL-C and VLDL-C estimation in familial combined hyperlipidemia using Sampson's, Martin's and Friedewald's equations.

Authors: Vargas-Vázquez, Arsenio Bello-Chavolla, Omar Yaxmehen Antonio-Villa, Neftali Eduardo et al.

Source: Lipids in Health & Disease. 5/5/2021, Vol. 20 Issue 1, p1-9. 9p.

Factors associated with postprandial lipemia and apolipoprotein A-V levels in individuals with familial combined hyperlipidemia.

Authors: Almeda-Valdes, Paloma Cuevas-Ramos, Daniel Mehta, Roopa et al.

Source: BMC Endocrine Disorders. 2014, Vol. 14 Issue 1, p43-60. 18p. 3 Charts, 2 Graphs.